These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 139359)

  • 1. Immunologically mediated macrophage aggregation in monolayers of peritoneal cells from BCG-sensitized mice.
    Preston PM; Hart PD; Brown IN
    Immunology; 1977 Jan; 32(1):33-41. PubMed ID: 139359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of carrier-mediated transport after immunologic activation of peritoneal macrophages.
    Bonventre PF; Straus D; Baughn RE; Imhoff J
    J Immunol; 1977 May; 118(5):1827-35. PubMed ID: 404359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of migration inhibiting factor(s) on the in vitro detachment of macrophages.
    Weiss L; Glaves D
    J Immunol; 1975 Nov; 115(5):1362-5. PubMed ID: 1100729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of BCG cell wall-induced delayed-type hypersensitivity by BCG pre-treatment. II. Induction of suppressor T cells by heat-killed BCG injection.
    Kato K; Yamamoto K
    Immunology; 1982 Apr; 45(4):655-61. PubMed ID: 6175566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage activation for tumor cytotoxicity: induction of tumoricidal macrophages by supernatants of PPD-stimulated Bacillus Calmette-Guérin-immune spleen cell cultures.
    Ruco LP; Meltzer MS
    J Immunol; 1977 Sep; 119(3):889-96. PubMed ID: 330759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-enhanced glucosamine incorporation by peritoneal macrophages in cell-mediated hypersensitivity. I. Studies on biology and mechanism.
    Hammond ME; Selvaggio SS; Dvorak HF
    J Immunol; 1975 Oct; 115(4):914-21. PubMed ID: 1100724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and functional characteristics of the plasma membrane of macrophages from BCG-infected mice.
    Edelson PJ; Erbs C
    J Immunol; 1978 May; 120(5):1532-6. PubMed ID: 351053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Migration of natural suppressor cells from bone marrow to peritoneal cavity by live BCG.
    Kato K; Yamamoto K; Kimura T
    J Immunol; 1985 Dec; 135(6):3661-8. PubMed ID: 2933452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guinea pig lymphocyte-derived macrophage aggregation factor: its separation from macrophage migration inhibitory factor.
    Postlethwaite AE; Kang AH
    J Immunol; 1976 Nov; 117(5 Pt 1):1651-5. PubMed ID: 794415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic expression of genetically-controlled natural resistance to Mycobacterium bovis (BCG).
    Stach JL; Gros P; Forget A; Skamene E
    J Immunol; 1984 Feb; 132(2):888-92. PubMed ID: 6361135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental studies of tumor immunotherapy. I. Macrophage migration inhibitory activity as an immunological parameter.
    Hayashi S
    Acta Med Okayama; 1976 Apr; 30(2):95-106. PubMed ID: 135489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination.
    Young SL; Slobbe L; Wilson R; Buddle BM; de Lisle GW; Buchan GS
    Infect Immun; 2007 Jun; 75(6):2833-40. PubMed ID: 17371857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endotoxin-induced interferon-gamma production in culture cells derived from BCG-infected C3H/HeJ mice.
    Matsumura H; Nakano M
    J Immunol; 1988 Jan; 140(2):494-500. PubMed ID: 3121747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro quantitation of cell-mediated immunity in guinea-pigs by macrophage reduction of nitro-blue tetrazolium.
    Krueger GG; Ogden BE; Weston WL
    Clin Exp Immunol; 1976 Mar; 23(3):517-24. PubMed ID: 780014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacille Calmette-Guérin infection in the mouse. Regulation of macrophage plasminogen activator by T lymphocytes and specific antigen.
    Gordon S; Cohn ZA
    J Exp Med; 1978 Apr; 147(4):1175-88. PubMed ID: 349108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of in vitro cytotoxic responses by BCG-induced macrophage-like suppressor cells. II. Suppression occurs at the level of a "helper" T cell.
    Klimpel GR; Okada M; Henney CS
    J Immunol; 1979 Jul; 123(1):350-7. PubMed ID: 156233
    [No Abstract]   [Full Text] [Related]  

  • 17. Suppression of BCG cell wall-induced delayed-type hypersensitivity by pretreatment with killed BCG: induction of nonspecific suppressor T cells by the adjuvant portion (MDP) and of specific suppressor T cells by the antigen portion (TAP).
    Kato K; Yamamoto K; Kimura T; Azuma I; Askenase PW
    J Immunol; 1984 Jun; 132(6):2790-5. PubMed ID: 6202761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphokines in sensitized rats. I. Migration inhibitory factor(s) from specifically stimulated thymocytes in vitro.
    Bakker WW; Engelhart JJ; Mulder I; Hoedemaeker PJ
    Int Arch Allergy Appl Immunol; 1975; 49(4):491-503. PubMed ID: 1099009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of cytokines and nitric oxide in the induction of tuberculostatic macrophage functions.
    Petricevich VL; Alves RC
    Mediators Inflamm; 2000; 9(6):261-9. PubMed ID: 11213909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage fusion factor elicited from BGG-sensitized lymphocytes.
    Warfel AH; Hadden JW
    Am J Pathol; 1978 Dec; 93(3):753-70. PubMed ID: 362945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.